ֱ

Dyanavel XR OK'd in Ages 6 and Up; ADHDTok; Depression Among LGBT Native Americans

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

The FDA approved extended release, once-daily for patients ages 6 and older with attention deficit-hyperactivity disorder (ADHD), Tris Pharma announced.

In related news, a subculture on is prompting many users to seek assessment for ADHD symptoms. (Insider)

The is cracking down on pharmacies dispensing buprenorphine. (NPR)

, CBE, FRS, FRCP, FRCPsych, dubbed the "father of child psychiatry," passed away at age 88. (New York Times)

A new study found 42% of lesbian, gay, bisexual, and transgender were diagnosed with depression compared with only 6.7% of the general population. (NBC News)

Kids who are are two times as likely to initiate treatment for it, according to a 3-year study. (U.S. News & World Report)

How might transform the scope of psychiatric treatment? (The Guardian)

Two owners of were convicted by a federal jury for fraudulently billing roughly $112 million in services not rendered or that were medically unnecessary. ( National Law Review)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.